Heitner BioInnovation ApS: Financial statements 2024
CVR: 41712937
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Heitner BioInnovation ApS (CVR 41712937) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -1,228 and a net result of DKK -1,228 compared with DKK -1,109 the year before. Equity in the 2024 report amounted to DKK 17,413. The solvency ratio was 100%.
- Gross Profit
- DKK -1,228
- Profit/Loss
- DKK -1,228
- Equity
- DKK 17,413
- Total Assets
- DKK 17,413
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -1K | -1K | 17K | - |
| 2023 | - | -1K | -1K | 19K | - |
| 2022 | - | - | -600 | 20K | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
Heitner BioInnovation ApS has published its annual report for 2023. Gross profit came to DKK -1,109, and the net result was DKK -1,109.
About Heitner BioInnovation ApS
Heitner BioInnovation ApS is a Danish company of the type Anpartsselskab based in Bagsværd, founded in 2020. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Tara Renée Heitner. The company is owned by Tara Renée Heitner. In 2025, the company reported a gross profit of DKK -454 and a net result of DKK -454 compared with DKK -1,228 the year before. Equity in the 2025 report amounted to DKK 16,959.